Wonbiogen Co., Ltd. (KOSDAQ:307280)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,230.00
-10.00 (-0.14%)
At close: Mar 6, 2026
27.51%
Market Cap 49.01B
Revenue (ttm) 34.38B
Net Income (ttm) 6.62B
Shares Out 7.09M
EPS (ttm) 930.43
PE Ratio 7.43
Forward PE n/a
Dividend 140.00 (1.94%)
Ex-Dividend Date Dec 29, 2025
Volume 31,729
Average Volume 74,339
Open 7,200.00
Previous Close 7,240.00
Day's Range 7,110.00 - 7,300.00
52-Week Range 4,765.00 - 8,400.00
Beta 0.68
RSI 40.44
Earnings Date Mar 20, 2026

About Wonbiogen

Wonbiogen Co., Ltd. manufactures and sells wound dressings in South Korea, rest of Asia, Europe, and internationally. It operates through Wound Dressing and Daily Necessities divisions. The company offers polyurethane foam and hydrocolloid dressings; cosmetics; other dressings; and daily necessities. It also provides medical, organic, and inorganic materials; and laundry detergents. Wonbiogen Co., Ltd. was founded in 2006 and is headquartered in Gumi-si, South Korea. [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2006
Employees 77
Stock Exchange KOSDAQ
Ticker Symbol 307280
Full Company Profile

Financial Performance

In 2024, Wonbiogen's revenue was 30.44 billion, an increase of 2.79% compared to the previous year's 29.61 billion. Earnings were 5.69 billion, an increase of 3.50%.

Financial Statements

News

There is no news available yet.